Search   
MSDS  : Pyrimidine, 2,4-diamino-5-(3,4,5-trimethoxybenzyl)- and N'-(5-methyl-3-isoxazolyl) sulfanilamide
CAS  : 8064-90-2
SYNONYMS  : * A 033 * Abacin * Abactrim * Alfatrim * Aposulfatrim * Bactrim * Bactrim Forte * Bactromin * Baktar * Biseptol * Chemitrim * CO-Trimoxazole * Drylin * Duon * Eltrianyl * Eusaprim * Fectrim * Gantaprin * Gantrim * Kepinol * Kepinol Forte * Linaris * Microtrim * Momentol * Nopil * Omsat * Oriprim * Oxaprim * Pantoprim * Septra * Septran * Septrin * Sigaprin * Sulfamethoxazol-trimethoprim * Sulfatrim * Sulfotrimin * Sulprim * Sumetrolim * Tacumil * Teleprin * TMS 480 * Trigonyl * Trimesulf * Trimethoprimsulfa * Trimethoprim-sulfamethoxazole * Trimethoprim and sulphamethoxazole * Trimforte * Trimosulfa * Uro-septra
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : UV8240000
CHEMICAL NAME : Pyrimidine, 2,4-diamino-5-(3,4,5-trimethoxybenzyl)-
and N'-(5-methyl-3-isoxazolyl) sulfanilamide
CAS REGISTRY NUMBER : 8064-90-2
OTHER CAS REGISTRY NOS. : 74711-00-5
LAST UPDATED : 199712
DATA ITEMS CITED : 15
MOLECULAR FORMULA : C14-H18-N4-O3.C10-H11-N3-O3-S
MOLECULAR WEIGHT : 543.66
COMPOUND DESCRIPTOR : Tumorigen
Drug
Human
SYNONYMS/TRADE NAMES :
* A 033
* Abacin
* Abactrim
* Alfatrim
* Aposulfatrim
* Bactrim
* Bactrim Forte
* Bactromin
* Baktar
* Biseptol
* Chemitrim
* CO-Trimoxazole
* Drylin
* Duon
* Eltrianyl
* Eusaprim
* Fectrim
* Gantaprin
* Gantrim
* Kepinol
* Kepinol Forte
* Linaris
* Microtrim
* Momentol
* Nopil
* Omsat
* Oriprim
* Oxaprim
* Pantoprim
* Septra
* Septran
* Septrin
* Sigaprin
* Sulfamethoxazol-trimethoprim
* Sulfatrim
* Sulfotrimin
* Sulprim
* Sumetrolim
* Tacumil
* Teleprin
* TMS 480
* Trigonyl
* Trimesulf
* Trimethoprimsulfa
* Trimethoprim-sulfamethoxazole
* Trimethoprim and sulphamethoxazole
* Trimforte
* Trimosulfa
* Uro-septra

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - child
DOSE/DURATION : 432 mg/kg/9D-I
TOXIC EFFECTS :
Blood - thrombocytopenia
REFERENCE :
SMJOAV Southern Medical Journal. (Southern Medical Assoc., POB 2446,
Birmingham, AL 35205) V.1- 1908- Volume(issue)/page/year: 76,503,1983

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human
DOSE/DURATION : 274 mg/kg/10D-I
TOXIC EFFECTS :
Cardiac - pulse rate increase, without fall in BP
Lungs, Thorax, or Respiration - cyanosis
Kidney, Ureter, Bladder - urine volume decreased
REFERENCE :
LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823-
Volume(issue)/page/year: 1,831,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 19 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - dyspnea
Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
AIMEAS Annals of Internal Medicine. (American College of Physicians, 4200
Pine St., Philadelphia, PA 19104) V.1- 1927- Volume(issue)/page/year:
106,331,1987

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - man
DOSE/DURATION : 457 mg/kg/5D-I
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
Endocrine - hypoglycemia
REFERENCE :
NYSJAM New York State Journal of Medicine. (Medical Soc. of the State of
New York, POB 5405, Lake Success, NY 11042) V.1- 1901-
Volume(issue)/page/year: 84,30,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Human - man
DOSE/DURATION : 80 mg/kg/4D-I
TOXIC EFFECTS :
Nutritional and Gross Metabolic - other changes
REFERENCE :
AIMEAS Annals of Internal Medicine. (American College of Physicians, 4200
Pine St., Philadelphia, PA 19104) V.1- 1927- Volume(issue)/page/year:
103,161,1985

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Unreported
SPECIES OBSERVED : Human - man
DOSE/DURATION : 576 mg/kg/1W-I
TOXIC EFFECTS :
Gastrointestinal - changes in structure or function of endocrine pancreas
REFERENCE :
AIMEAS Annals of Internal Medicine. (American College of Physicians, 4200
Pine St., Philadelphia, PA 19104) V.1- 1927- Volume(issue)/page/year:
104,363,1986

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 5350 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis
Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 12,2716,1978

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1840 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
Behavioral - somnolence (general depressed activity)
Lungs, Thorax, or Respiration - acute pulmonary edema
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
21,175,1973

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
21,175,1973

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 3740 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
Behavioral - ataxia
Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 12,2716,1978

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2010 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
Lungs, Thorax, or Respiration - acute pulmonary edema
Lungs, Thorax, or Respiration - dyspnea
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
21,175,1973

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
21,175,1973

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 54 gm/kg/30D-I
TOXIC EFFECTS :
Endocrine - changes in thyroid weight
Blood - pigmented or nucleated red blood cells
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
21,175,1973

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - X3841
No. of Facilities: 123 (estimated)
No. of Industries: 1
No. of Occupations: 5
No. of Employees: 1487 (estimated)
No. of Female Employees: 898 (estimated)

*** STATUS IN U.S. ***

NTP Carcinogenesis studies; selected, October 1997


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
2,4-Pyrimidinediamine,5-((4-(dimethylamino)-3,5-dimethoxyphenyl)methyl)- 56066-63-8
2,4-Pyrimidinediamine, N(sup4)-(2-(dimethylamino)ethyl)-6-methoxy-N(sup2)-methyl-5- (methylthio)-N(sup 2)-phenyl-,monohydrobromide 55417-13-5
2,4-Pyrimidinediamine, N(sup4)-(2-(dimethylamino)ethyl)-N(sup 2),N(sup2)-dimethyl-5- (methylthio)-6-(3-pyridinylmethoxy)-,dihydrobromide 55417-11-3
Pyrimidine,4-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methyl-2-((1-methylethyl)thio)- 154496-72-7
2,4-Pyrimidinediamine,6-(4-((5-fluoro-2-benzofuranyl)methyl)-1-piperazinyl)-N,N'-di-2- propenyl-, (E)-2-butenedioate (1:1) 87813-89-6
2,4-Pyrimidinediamine,6-(4-((5-fluoro-2H-1-benzopyran-3-yl)methyl)-1-piperazinyl)-N,N'-di-2- propenyl-, (E)-2-butenedioate (1:1) 87813-91-0
5-Pyrimidinecarboxamide,N-(1-benzyl-4-piperidyl)-4-methoxy-2-methyl-, maleate 72412-54-5
4,6-Pyrimidinediamine,2,2'-(1,6-hexanediylbis(thio))bis- 92629-39-5
2,4-Pyrimidinediamine, 6-(2-methylpropyl)-5-phenyl- 35650-72-7
4,6-Pyrimidinediamine,2,2'-(1,5-pentanediylbis(thio))bis- 92629-38-4
2,4-Pyrimidinediamine, 5-phenyl-6-(phenylmethyl)- 35650-73-8
2,4-Pyrimidinediamine, 6,6'-(1,4-piperazinediyl)bis-,3,3'-dioxide 83540-33-4
Pyrimidine, 2,4-diamino-6-(p-arsenosoanilino)- 34388-37-9
Pyrimidine, 2,4-diamino-5-(p-bromophenyl)-6-methyl- 7331-25-1
Pyrimidine, 2,4-diamino-5-(p-chlorobenzyl)-6-methyl- 7331-23-9
Pyrimidine, 2,4-diamino-5-(p-chlorophenoxy)- 7331-20-6
Pyrimidine, 2,4-diamino-5-(p-chlorophenoxy)-6-methyl- 7331-19-3
5-Pyrimidinecarboxamide,N-((1-benzyl-2-pyrrolidinyl)methyl)-2-(dimethylamino)-4-methoxy-, dihydrochloride 84332-26-3
Pyrimidine,2,4-diamino-5-(3,4-dichlorophenyl)-6-ethyl- 18588-57-3
Pyrimidine,2,4-diamino-5-(3,4-dichlorophenyl)-6-methyl- 7761-45-7
Pyrimidine, 2,4-diamino-6-(2-(diethylamino)ethoxy)- 7520-51-6
Pyrimidine,2,4-diamino-5-(3,5-dimethoxy-4-(2-methoxyethoxy)benzyl)- 53808-87-0
Pyrimidine,2,4-diamino-5-((2,6-dimethoxy-3-pyridyl)methyl)- 65873-69-0
Pyrimidine,2,4-diamino-5-((2,6-dimethoxy-4-pyridyl)methyl)- 65873-57-6
Pyrimidine,2,4-diamino-5-((5,6-dimethoxy-3-pyridyl)methyl)- 52606-05-0
Pyrimidine, 2,4-diamino-6-(2-(dimethylamino)ethoxy)- 7520-50-5
Pyrimidine, 2,4-diamino-6-ethyl-5-phenyl- 27653-49-2
Pyrimidine,2,4-diamino-6-ethyl-5-(p-(trifluoromethoxy)phenyl)- 49561-95-7
5-Pyrimidinecarboxamide,N-((1-benzyl-2-pyrrolidinyl)methyl)-4-methoxy-,dihydrochloride, hydrate 84332-27-4
Pyrimidine, 2,4-diamino-6-isopropyl-5-phenyl- 34062-03-8
Pyrimidine,2,4-diamino-5-((6-methoxy-3-pyridyl)methyl)- 34062-03-8
Pyrimidine, 2,4-diamino-6-methyl-5-(p-nitrobenzyl)- 7331-21-7
Pyrimidine, 2,4-diamino-6-methyl-5-phenyl- 18588-50-6
Pyrimidine, 2,4-diamino-6-methyl-5-phenylazo- 34289-21-9
Pyrimidine, 2,4-diamino-6-(4-methyl-1-piperazinyl)-,3-oxide, dihydrochloride, hydrate 83540-32-3
Pyrimidine, 2,4-diamino-5-phenyl- 18588-49-3
Pyrimidine, 2,4-diamino-5-phenyl-6-propyl- 27653-50-5
Pyrimidine, 2,4-diamino-6-(1-piperazinyl)-, 3-oxide,dihydrochloride, hydrate 83540-31-2
Pyrimidine, 2,4-diamino-6-piperidino-, 3-oxide 38304-91-5
5-Pyrimidinecarboxamide,N-((1-benzyl-2-pyrrolidinyl)methyl)-4-methoxy-2-(methylamino)-, dihydrochloride 84332-25-2
Pyrimidine, 2,4-diamino-5-(2-pyridylmethyl)- 65873-50-9
Pyrimidine, 2,4-diamino-5-(3-pyridylmethyl)- 52606-04-9
Pyrimidine, 2,4-diamino-5-(4-pyridylmethyl)- 65873-56-5
Pyrimidine, 2,4-diamino-5-(3-pyridylmethyl)-, N(sup5)-oxide 65873-74-7
Pyrimidine, 2,4-diamino-5-(4-pyridylmethyl)-, N(sup5)-oxide 65873-75-8
Pyrimidine,2,4-diamino-6-(4-(2-pyridyl)-1-piperazinyl)-,3-oxide, dihydrochloride 83540-38-9
Pyrimidine,2,4-diamino-5-(m-(trifluoromethoxy)benzyl)- 50823-99-9
Pyrimidine,2,4-diamino-5-(m-(trifluoromethyl)benzyl)- 50823-94-4
Pyrimidine, 2,4-diamino-5-(3,4,5-trimethoxybenzyl)- 738-70-5
Pyrimidine, 2,4-diamino-5-(3,4,5-trimethoxybenzyl)-and N'-(5-methyl-3-isoxazolyl) sulfanilamide 8064-90-2

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net